Cargando…

FABREX: A NEW CLINICAL TEST FOR DIAGNOSIS GLUTEAL TENDINOPATHY

OBJECTIVE: This study aims to describe a simple and accurate semiological method executing a specific maneuver with the lower limb to direct the semiological investigation towards the tendinopathies in the gluteus medius and minimus. METHODS: Fifty patients participated in the study, with a mean age...

Descripción completa

Detalles Bibliográficos
Autores principales: FREITAS, ANDERSON, ROSA, TATIANE MORELATI, MACEDO NETO, SILVIO LEITE DE, BANDEIRA, VANESSA DE CARVALHO, SOUTO, DIOGO RANIER DE MACEDO, BARIN, FABRÍCIO REICHERT
Formato: Online Artículo Texto
Lenguaje:English
Publicado: ATHA EDITORA 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9210511/
https://www.ncbi.nlm.nih.gov/pubmed/35765571
http://dx.doi.org/10.1590/1413-785220223002241045
_version_ 1784730172935634944
author FREITAS, ANDERSON
ROSA, TATIANE MORELATI
MACEDO NETO, SILVIO LEITE DE
BANDEIRA, VANESSA DE CARVALHO
SOUTO, DIOGO RANIER DE MACEDO
BARIN, FABRÍCIO REICHERT
author_facet FREITAS, ANDERSON
ROSA, TATIANE MORELATI
MACEDO NETO, SILVIO LEITE DE
BANDEIRA, VANESSA DE CARVALHO
SOUTO, DIOGO RANIER DE MACEDO
BARIN, FABRÍCIO REICHERT
author_sort FREITAS, ANDERSON
collection PubMed
description OBJECTIVE: This study aims to describe a simple and accurate semiological method executing a specific maneuver with the lower limb to direct the semiological investigation towards the tendinopathies in the gluteus medius and minimus. METHODS: Fifty patients participated in the study, with a mean age of 44.1 ± 13 years, with persistent pain on the side of the hip for more than three months. To compare the FABREX (proposed test) and Lequesne semiological tests, in the diagnosis of tendinopathies in the gluteus medius and minimus, Magnetic Resonance Imaging (MRI) was adopted as the gold standard. RESULTS: FABREX presented high sensitivity and moderate specificity for tendinopathy in the gluteus medius and high sensitivity and specificity for tendinopathy in the gluteus minimus. CONCLUSION: The proposed test, when positive, can be used to determine the diagnosis of gluteal tendinopathies (high specificity). Moreover, it has high sensitivity, excluding the diagnosis when negative. This study represents the initial step for validating the FABREX test, and can therefore be considered a simple and accurate procedure to identify patients with or without gluteal tendinopathies. Level of Evidence III, Case Control Study.
format Online
Article
Text
id pubmed-9210511
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher ATHA EDITORA
record_format MEDLINE/PubMed
spelling pubmed-92105112022-06-27 FABREX: A NEW CLINICAL TEST FOR DIAGNOSIS GLUTEAL TENDINOPATHY FREITAS, ANDERSON ROSA, TATIANE MORELATI MACEDO NETO, SILVIO LEITE DE BANDEIRA, VANESSA DE CARVALHO SOUTO, DIOGO RANIER DE MACEDO BARIN, FABRÍCIO REICHERT Acta Ortop Bras Original Article OBJECTIVE: This study aims to describe a simple and accurate semiological method executing a specific maneuver with the lower limb to direct the semiological investigation towards the tendinopathies in the gluteus medius and minimus. METHODS: Fifty patients participated in the study, with a mean age of 44.1 ± 13 years, with persistent pain on the side of the hip for more than three months. To compare the FABREX (proposed test) and Lequesne semiological tests, in the diagnosis of tendinopathies in the gluteus medius and minimus, Magnetic Resonance Imaging (MRI) was adopted as the gold standard. RESULTS: FABREX presented high sensitivity and moderate specificity for tendinopathy in the gluteus medius and high sensitivity and specificity for tendinopathy in the gluteus minimus. CONCLUSION: The proposed test, when positive, can be used to determine the diagnosis of gluteal tendinopathies (high specificity). Moreover, it has high sensitivity, excluding the diagnosis when negative. This study represents the initial step for validating the FABREX test, and can therefore be considered a simple and accurate procedure to identify patients with or without gluteal tendinopathies. Level of Evidence III, Case Control Study. ATHA EDITORA 2022-04-15 /pmc/articles/PMC9210511/ /pubmed/35765571 http://dx.doi.org/10.1590/1413-785220223002241045 Text en https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License
spellingShingle Original Article
FREITAS, ANDERSON
ROSA, TATIANE MORELATI
MACEDO NETO, SILVIO LEITE DE
BANDEIRA, VANESSA DE CARVALHO
SOUTO, DIOGO RANIER DE MACEDO
BARIN, FABRÍCIO REICHERT
FABREX: A NEW CLINICAL TEST FOR DIAGNOSIS GLUTEAL TENDINOPATHY
title FABREX: A NEW CLINICAL TEST FOR DIAGNOSIS GLUTEAL TENDINOPATHY
title_full FABREX: A NEW CLINICAL TEST FOR DIAGNOSIS GLUTEAL TENDINOPATHY
title_fullStr FABREX: A NEW CLINICAL TEST FOR DIAGNOSIS GLUTEAL TENDINOPATHY
title_full_unstemmed FABREX: A NEW CLINICAL TEST FOR DIAGNOSIS GLUTEAL TENDINOPATHY
title_short FABREX: A NEW CLINICAL TEST FOR DIAGNOSIS GLUTEAL TENDINOPATHY
title_sort fabrex: a new clinical test for diagnosis gluteal tendinopathy
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9210511/
https://www.ncbi.nlm.nih.gov/pubmed/35765571
http://dx.doi.org/10.1590/1413-785220223002241045
work_keys_str_mv AT freitasanderson fabrexanewclinicaltestfordiagnosisglutealtendinopathy
AT rosatatianemorelati fabrexanewclinicaltestfordiagnosisglutealtendinopathy
AT macedonetosilvioleitede fabrexanewclinicaltestfordiagnosisglutealtendinopathy
AT bandeiravanessadecarvalho fabrexanewclinicaltestfordiagnosisglutealtendinopathy
AT soutodiogoranierdemacedo fabrexanewclinicaltestfordiagnosisglutealtendinopathy
AT barinfabricioreichert fabrexanewclinicaltestfordiagnosisglutealtendinopathy